ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 23 filers reported holding ENZYMOTEC LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $207,000 | -87.0% | 17,913 | -90.9% | 0.00% | -85.7% |
| Q2 2017 | $1,592,000 | -23.8% | 196,306 | -17.2% | 0.01% | -30.0% |
| Q1 2017 | $2,088,000 | +38.6% | 237,184 | +3.2% | 0.01% | +42.9% |
| Q4 2016 | $1,506,000 | -5.5% | 229,862 | +0.7% | 0.01% | -12.5% |
| Q3 2016 | $1,594,000 | -23.2% | 228,304 | -8.1% | 0.01% | -27.3% |
| Q2 2016 | $2,076,000 | +36.3% | 248,317 | +47.2% | 0.01% | +37.5% |
| Q1 2016 | $1,523,000 | +31.6% | 168,738 | +42.9% | 0.01% | +33.3% |
| Q4 2015 | $1,157,000 | +149.4% | 118,072 | +129.8% | 0.01% | +100.0% |
| Q3 2015 | $464,000 | +714.0% | 51,370 | +647.4% | 0.00% | – |
| Q2 2015 | $57,000 | +16.3% | 6,873 | 0.0% | 0.00% | – |
| Q1 2015 | $49,000 | -7.5% | 6,873 | 0.0% | 0.00% | – |
| Q4 2014 | $53,000 | +15.2% | 6,873 | 0.0% | 0.00% | – |
| Q3 2014 | $46,000 | -77.0% | 6,873 | -53.3% | 0.00% | -100.0% |
| Q2 2014 | $200,000 | -86.1% | 14,713 | -77.6% | 0.00% | -87.5% |
| Q1 2014 | $1,442,000 | +111.4% | 65,575 | +159.5% | 0.01% | +100.0% |
| Q4 2013 | $682,000 | – | 25,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 677,548 | $4,743,000 | 1.12% |
| Gagnon Advisors, LLC | 190,176 | $1,331,000 | 1.05% |
| GAGNON SECURITIES LLC | 238,627 | $1,670,000 | 0.71% |
| Paulson & Co. | 4,205,980 | $29,442,000 | 0.32% |
| ALGERT GLOBAL LLC | 50,566 | $354,000 | 0.10% |
| MENTA CAPITAL LLC | 50,498 | $353,000 | 0.03% |
| TFS CAPITAL LLC | 13,375 | $94,000 | 0.02% |
| ICON ADVISERS INC/CO | 31,417 | $220,000 | 0.02% |
| Laurion Capital Management LP | 152,813 | $1,070,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 228,304 | $1,594,000 | 0.01% |